Future Hereditary of Rare Diseases and Orphan Drugs

Work over the past 25 years has resulted in the identification of genes responsible for ~50% of the estimated 7,000 rare monogenic diseases and it is predicted that most of the remaining disease-causing genes will be identified by the year 2020 and probably sooner. This marked acceleration is the result of dramatic improvements in DNA-sequencing technologies and the associated analyses. We examine the rapid maturation of rare-disease genetic analysis and successful strategies for gene identification. We highlight the impact of discovering rare-disease-causing genes, from clinical diagnostics to insights gained into biological mechanisms and common diseases. Last, we explore the increasing therapeutic opportunities and challenges that the resulting expansion of the 'Atlas' of human genetic pathology will bring.

    Related Conference of Future Hereditary of Rare Diseases and Orphan Drugs

    December 11-12, 2025

    8th Annual Congress on Bacterial, Viral and Infectious Diseases

    Prague, Czech Republic
    December 15-16, 2025

    7th Global Experts Meeting on Infectious Diseases

    Barcelona, Spain
    December 17-18, 2025

    17th Global Conference on Nephrology and Infectious Diseases

    Amsterdam, Netherlands
    May 18-19, 2026

    15th World Congress on Rare Diseases and Orphan Drugs

    Prague, Czech Republic

    Future Hereditary of Rare Diseases and Orphan Drugs Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in